AI assistant
NEXT Biometrics Group ASA — Share Issue/Capital Change 2014
Jun 18, 2014
3671_iss_2014-06-18_842ad077-8db2-4b89-9a84-e1bfc93e9f10.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
NEXT Biometrics Group - Status of bookbuilding
NEXT Biometrics Group - Status of bookbuilding
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR
INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA,
AUSTRALIA, HONG KONG OR JAPAN OR ANY OTHER
JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE
WOULD BE UNLAWFUL
PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS
STOCK EXCHANGE NOTICE
NEXT Biometrics Group - Status of bookbuilding
Oslo, 18 June 2014: Reference is made to the stock
exchange releases from the NEXT Biometrics Group ASA
("NEXT Biometrics" or the "Company") dated 6 June
2014 and 11 June 2014.
Since the start of the Bookbuilding Period, the joint
bookrunners, Arctic Securities ASA and Carnegie AS,
have experienced solid interest from investors. The
joint bookrunners have received orders which more
than cover the maximum deal size of 2,400,000 New
Shares and up to 130,000 Sale Shares as well as the
15% over-allotment option offered by the Company.
Based on the orders received and the composition of
the institutional book of demand, the Offering is
expected to be priced at a minimum of NOK 80 per
Offer Share.
The Bookbuilding Period for the Institutional
Offering runs until 16:30 CET on 19 June 2014 and the
Application Period for the Retail Offering runs until
12:00 CET on 19 June 2014, both subject to shortening
or extension.
About NEXT Biometrics:
Enabled by its patented Active Thermal Principle,
NEXT Biometrics offers high quality area fingerprint
sensor at low prices. A wide range of products format
including Smartphones, tablets, PC's, doors, time
registration systems, payment terminals, flashdrives,
USB-tokens, keyfobs and many more are targeted. NEXT
Biometrics is headquartered in Oslo, Norway, with
sales, support and development subsidiaries in
Seattle, Taipei and Shanghai.
For more information about the company, please visit
www.nextbiometrics.com.
IMPORTANT NOTICE:
These materials are not an offer for sale of
securities.
Copies of this announcement are not being made and
may not be distributed or sent into the United
States, Canada, Australia, Hong Kong, Japan or any
other jurisdiction in which such distribution would
be unlawful or would require registration or other
measures.
The securities have not been registered under the
U.S. Securities Act of 1933, as amended
(the "Securities Act"), and may not be offered or
sold in the United States absent registration or an
exemption from the registration requirements of the
Securities Act. The Company does not intend to
register any part of the offering in the United
States or to conduct a public offering of securities
in the United States.
Any offering of securities will be made by means of a
prospectus that may be obtained from the issuer or
selling security holder and that will contain
detailed information about the Company and
management, as well as financial statements. This
document is an advertisement and not a prospectus for
the purposes of Directive 2003/71/EC (together with
any applicable implementing measures in any Member
State, the "Prospectus Directive"). Investors should
not subscribe for any securities referred to in this
document except on the basis of information contained
in the prospectus.
In any EEA Member State other than Norway that has
implemented the Prospectus Directive, this
communication is only addressed to and is only
directed at qualified investors in that Member State
within the meaning of the Prospectus Directive, i.e.,
only to investors who can receive the offer without
an approved prospectus in such EEA Member State.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR
INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES, AUSTRALIA, CANADA
OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE
DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
This communication is only being distributed to and
is only directed at (i) persons who are outside the
United Kingdom or (ii) to investment professionals
falling within Article 19(5) of the Financial
Services and Markets Act 2000 (Financial Promotion)
Order 2005 (the "Order") or (iii) above together
being referred to as "relevant persons"). The
securities are only available to, and any invitation,
offer or agreement to subscribe, purchase or
otherwise acquire such securities will be engaged in
only with, relevant persons. Any person who is not a
relevant person should not act or rely on this
document or any of its contents.
Matters discussed in this release may constitute
forward-looking statements. Forward-looking
statements are statements that are not historical
facts and may be identified by words such
as "believe," "expect," "anticipate," "intends," "esti
mate," "will," "may," "continue," "should" and
similar expressions. The forward-looking statements
in this release are based upon various assumptions,
many of which are based, in turn, upon further
assumptions. Although the Company believes that these
assumptions were reasonable when made, these
assumptions are inherently subject to significant
known and unknown risks, uncertainties, contingencies
and other important factors which are difficult or
impossible to predict and are beyond its control.
Such risks, uncertainties, contingencies and other
important factors could cause actual events to differ
materially from the expectations expressed or implied
in this release by such forward-looking statements.
The information, opinions and forward-looking
statements contained in this release speak only as at
its date, and are subject to change without notice.
This information is subject of the disclosure
requirements pursuant to section 5-12 of the
Norwegian Securities Trading Act.